There are currently no generic versions of Zolpimist (zolpidem oral spray) licensed for sale. Although the brand-name drug does not have any patents listed with the FDA, generic drug makers have opted not to manufacture any generic versions at this time. It is also unknown when to expect a generic version on the market.
Zolpimist® (zolpidem oral spray) is a prescription sleep medication. It is unique in that it comes as a fast-acting oral spray. It is approved to treat insomnia that is characterized by trouble falling asleep (as opposed to trouble staying asleep).
Zolpimist is made by Rechon Life Sciences AB and is marketed by ECR Pharmaceuticals. At this time, there are no generic versions of Zolpimist available.
There are no Zolpimist patents that are listed with the United States Food and Drug Administration (FDA) at this time. This suggests that a generic manufacturer could choose to make a generic version of Zolpimist at any time, although there are often other factors that might prevent this from happening.
At this time, it is not possible to predict when a generic version of Zolpimist might become available.
The answer is no. Zolpidem tartrate is the active ingredient in Zolpimist (as well as a few other medications) but is not a generic version of Zolpimist. What can be confusing is that, oftentimes, the active ingredient of any drug is referred to as the "generic name." The generic name is different from a generic version of a medicine. In order for there to be a generic version of a medicine, the original medicine must have gone off patent, and another company besides the original manufacturer must make the product.